Show simple item record

dc.contributor.authorBongomin, Felix
dc.contributor.authorFleischer, Brian
dc.contributor.authorOlum, Ronald
dc.contributor.authorNatukunda, Barbra
dc.contributor.authorKiguli, Sarah
dc.contributor.authorByakika-Kibwika, Pauline
dc.contributor.authorBaruch Baluku, Joseph
dc.contributor.authorNakwagala, Frederick Nelson
dc.date.accessioned2022-01-12T11:21:34Z
dc.date.available2022-01-12T11:21:34Z
dc.date.issued2021
dc.identifier.citationBongomin, F., Fleischer, B., Olum, R., Natukunda, B., Kiguli, S., Byakika-Kibwika, P., ... & Nakwagala, F. N. (2021, November). High Mortality During the Second Wave of the Coronavirus Disease 2019 (COVID-19) Pandemic in Uganda: Experience From a National Referral COVID-19 Treatment Unit. In Open Forum Infectious Diseases (Vol. 8, No. 11, p. ofab530). US: Oxford University Press. https://doi.org/10.1093/ofid/ofab530en_US
dc.identifier.otherhttps://doi.org/10.1093/ofid/ofab530
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/1218
dc.description.abstractWe evaluated clinical outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19) in the second wave of the pandemic in a national COVID-19 treatment unit (CTU) in Uganda. Methods. We conducted a retrospective cohort study of COVID-19 patients hospitalized at the Mulago National Referral Hospital CTU between May 1 and July 11, 2021. We performed Kaplan-Meier analysis to evaluate all-cause in-hospital mortality. Results. Of the 477 participants, 247 (52%) were female, 15 (3%) had received at least 1 dose of the COVID-19 vaccine, and 223 (46%) had at least 1 comorbidity. The median age was 52 (interquartile range, 41–65) years. More than 80% of the patients presented with severe (19%, n = 91) or critical (66%, n = 315) COVID-19 illness. Overall, 174 (37%) patients died. Predictors of all-cause in-hospital mortality were as follows; age ≥50 years (adjusted odds ratio [aOR], 1.9; 95% confidence interval [CI], 1.2–3.2; P = .011), oxygen saturation at admission of ≥92% (aOR, 0.97; 95% CI, 0.91–0.95; P < .001), and admission pulse rate of ≥100 beats per minute (aOR, 1.01; 95% CI, 1.00–1.02; P = .042). The risk of death was 1.4-fold higher in female participants compared with their male counterparts (hazards ratio, 1.4; 95% CI, 1.0–2.0; P = .025). Conclusions. In this cohort, where the majority of the patients presented with severe or critical illness, more than one third of the patients hospitalized with COVID-19 at a national CTU died of the illness.en_US
dc.language.isoenen_US
dc.publisherOpen Forum Infectious Diseasesen_US
dc.subjectCOVID-19en_US
dc.subjectMortalityen_US
dc.subjectHigh-dependency uniten_US
dc.subjectSecond waveen_US
dc.subjectUgandaen_US
dc.titleHigh Mortality During the Second Wave of the Coronavirus Disease 2019 (COVID-19) Pandemic in Uganda: Experience From a National Referral COVID-19 Treatment Uniten_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record